CION Ameerpet
Kidney Cancer · Treatment & Modalities
Immunotherapy side effects in kidney cancer — what to watch for, and how each one is managed
Immunotherapy side effects in kidney cancer are not the side effects most people are braced for. There is usually no hair loss and no collapse in blood counts. What happens instead is that the immune system, once its brake is released, occasionally turns its attention on healthy tissue — the thyroid, the bowel, the skin, the liver, the lungs, sometimes the kidney itself. These are called immune-related side effects, and the single most useful thing to know about them is that they respond well to being reported early and badly to being left. This page sets out where they appear, when, which ones need a phone call the same day, and exactly what your team does about each. For how the treatment itself works, see immunotherapy for advanced kidney cancer.
- The problem is inflammation, not poisoning — Immune toxicity is an over-active immune response in an organ that did not need one. That is why it is treated by damping the immune system down, not by waiting it out.
- Most are mild, and most are reversible — Skin, gut and liver inflammation usually settle fully once treated. The hormone glands are the main exception, and replacement is a tablet, not a crisis.
- Timing is the whole game — The same symptom reported in the first week and reported six weeks later are two very different problems. Never save it up for the next appointment.
- Managed in-house at CION — The infusions, the pre-cycle monitoring bloods and the treatment of any immune-related reaction are led by our own medical oncology team. Kidney surgery, ablation and PET-CT are coordinated with specialist partner centres.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Organ by organ
Where immunotherapy side effects show up, and what they feel like
Immune-related side effects are grouped by the organ the inflammation lands in, because that is what decides how they are treated. The list below is what your team asks about before every cycle. Not everyone gets any of it; almost nobody gets all of it. If you have not yet started treatment, how immunotherapy works in kidney cancer is the better place to begin, and the wider picture of the disease is in our kidney cancer guide.
| Where it lands | What you would notice | When it tends to appear | What your team does |
|---|---|---|---|
| Skin the commonest |
An itchy rash, dry patches, sometimes loss of skin colour in blotches. Usually a nuisance rather than a danger. | Often earliest — within the first few weeks. | Emollients, a steroid cream, an antihistamine for the itch. Treatment normally carries on. A spreading, blistering rash or one involving the mouth is a different matter and is seen urgently. |
| Thyroid and other hormone glands |
Tiredness, feeling cold, weight change, low mood if the gland is under-active; palpitations, heat intolerance and weight loss if it is briefly over-active. | Any time, often after the first couple of months, and sometimes gradually. | Picked up on the routine pre-cycle blood test before you feel much. Corrected with thyroid hormone replacement, and immunotherapy usually carries straight on. |
| Bowel colitis |
Loose motions more often than your normal, tummy cramps, urgency, and in more serious cases blood or mucus. | Commonly after several weeks to a couple of months. | This is the one not to sit on. Mild cases: fluids, diet advice, a dose hold. Moderate or severe: a corticosteroid course, sometimes admission and a second immune-suppressing drug class. |
| Liver hepatitis |
Usually nothing at all at first — it shows on a blood test. Later, yellowing of the eyes, dark urine, right-sided tummy discomfort, nausea. | Often around the second or third month. | Found by the pre-cycle liver bloods. Dose held and liver function repeated; a steroid course if the rise is significant, then a slow reduction with repeat testing. |
| Lungs pneumonitis |
A new dry cough, breathlessness on doing what you could do last month, chest tightness. Less common, but it needs acting on. | Any time during treatment, and occasionally after it ends. | Seen the same day, with a scan to separate it from infection or from the cancer itself. Treatment is held and a steroid course started; severe cases are admitted. |
| Kidney nephritis |
Usually silent. Sometimes less urine than normal, or swelling. It matters here because many people are already down one kidney after surgery. | Any time; detected on routine bloods. | Kidney function is on every pre-cycle blood panel. A rise means holding the dose, reviewing other medicines that stress the kidney, and a steroid course if it does not settle. |
| Joints and muscles | Aching, stiff joints in the morning, muscle soreness or weakness. Easy to attribute to age or to the cancer. | Variable, often later in a course. | Simple pain relief and physiotherapy first; a short steroid course if it is limiting what you can do. Worth mentioning even when it seems minor. |
| Pituitary and adrenal glands uncommon |
Deep tiredness with dizziness or faintness on standing, persistent headache, nausea, occasionally a change in vision. | Uncommon, but more likely where a CTLA-4 inhibitor is part of the treatment. | Assessed urgently, because the hormones these glands control keep blood pressure and salt balance steady. Managed with hormone replacement, often long term. |
Two things change this picture. Combination immunotherapy — two immune agents together — brings reactions on earlier and more often than a single agent, while a checkpoint inhibitor paired with a VEGF TKI adds the targeted drug’s own effects, such as raised blood pressure and sore hands and feet, which are dose-related and separate from immune inflammation. Which combination you are on therefore changes what to watch for. The regimens themselves, and what each costs, are set out on kidney cancer treatment in Hyderabad.
Ring your team the same day — do not wait for the next appointment.
Diarrhoea that is more frequent than usual or not settling, especially with tummy pain, blood or mucus. New breathlessness or a dry cough. Yellowing of the eyes or skin, or very dark urine. A rash that is spreading, blistering, or involving the mouth. Severe tiredness with dizziness or faintness on standing. A persistent new headache or a change in vision. Passing much less urine than usual. None of these means something has gone badly wrong — they are the symptoms that are straightforward to settle when they are caught in days and stubborn when they are left for weeks. If you are a CION patient, that call goes to your medical oncology team; if you are being treated elsewhere and want a second view, book a free consultation.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A side effect is a reason to call, not a reason to give up on the treatment
Most immune reactions are held, treated and got past. Send us your reports and we will tell you whether what you are describing needs action today, and what your options are either way. Free first consultation, no commitment.
What happens after you report it
How an immune-related side effect is graded and managed
The response is not improvised. Immune toxicity is graded by how much it is interfering with you, and each grade has a defined answer along NCCN lines. Knowing the sequence makes the phone call easier to make, because you can see that reporting something does not automatically mean losing the treatment.
It is found by asking, as much as by testing
Before every cycle your blood counts, kidney function, liver function and thyroid results are checked, and you are asked in detail how the last cycle went. Some reactions — liver, kidney, thyroid — turn up on the bloods before you notice anything. Others — bowel, skin, lungs, joints — only exist as something you say out loud. That is why the questions can feel repetitive, and why the honest answer matters more than the polite one.
Other causes are ruled out first
Not every symptom on immunotherapy is caused by immunotherapy. Diarrhoea can be an infection. Breathlessness can be a chest infection, anaemia, or the cancer itself. Tiredness can be all three. So the first move is usually a test rather than a treatment: a stool test, a chest scan, bloods, sometimes a review of the other medicines you are taking. This matters, because damping the immune system down would be exactly the wrong answer for an infection.
Mild: treat the symptom, keep going
If the problem is not interfering much with your day, treatment usually continues while the symptom itself is managed — a cream and an antihistamine for a rash, fluids and diet advice for loose motions, simple pain relief for aching joints. You are asked to report it again if it worsens, and it is checked at the next visit rather than left to declare itself. Most immune-related side effects never get past this step.
Moderate: hold the dose, start a steroid
If it is limiting what you can do, the next dose is held and a corticosteroid is started, because a steroid damps down the immune response that is causing the inflammation. This is not a defeat and it does not usually undo the benefit of treatment. The steroid is then reduced slowly, over several weeks rather than days, because stopping abruptly is the commonest reason a reaction comes straight back. You will be reviewed through that taper.
Severe: admission, and a stronger hand
A small number of reactions — significant colitis, pneumonitis, hepatitis, or a hormone-gland problem affecting blood pressure — need admission, steroid given into a vein, and occasionally a second immune-suppressing drug class if the steroid alone is not enough by a few days. The relevant organ specialist is brought in. This is uncommon, and it is far less common in people who rang early than in people who waited.
Restart, replace, or change the plan
Once things settle there are three honest outcomes. Most often treatment restarts when the steroid dose is low enough. Sometimes the organ is simply replaced — an under-active thyroid is corrected with hormone replacement and treatment carries on. Less often, particularly after severe lung, liver, bowel or hormone-gland inflammation, that drug is stopped for good and an alternative is put forward. At CION this decision goes back to the tumour board, and you should get it in writing. Book a free consultation if you want a second view on where you are in that sequence.
Not obvious, but important
Six things worth knowing about immune side effects
None of these are technicalities. Each one changes what you should do, or what you should say to somebody, and when.
Say it out loud
Nothing is too small to mention
People routinely leave out an itchy patch, three loose motions a day, or morning stiffness, on the grounds that it is not worth bothering anyone with. Those are precisely the things that are easy to treat now and difficult to treat in a month. Bring a short written list to each visit rather than trying to recall three weeks at the door, and say when each thing started, not just that it is happening.
Tell every doctor
The immunotherapy stays on your record
Immune-related reactions can begin after the course has ended, sometimes months later. If you see a general physician, a dermatologist, a gastroenterologist or an emergency doctor for something new, say clearly that you have had immunotherapy and when. It changes what they should suspect and what they should not give you. Carry the treatment summary your oncologist gives you, and keep it with you rather than at home in a file.
Before you start
Some histories change the risk
An autoimmune condition, a transplanted organ, long-term steroid or immune-suppressing medicine, or active hepatitis all raise the chance of an immune reaction, because a brake is being released on a system that was already inclined to over-react. None of these is an automatic no, but each has to be weighed before the first dose rather than discovered afterwards. Bring your full medicine list, including anything for arthritis, thyroid disease, psoriasis or inflammatory bowel disease.
Steroids
Neither the enemy nor a thing to self-prescribe
A corticosteroid course is the standard treatment for a moderate immune reaction and it does not, in general, cancel out the benefit of immunotherapy. Two rules make it work: take it exactly as the taper is written, and never stop it abruptly, because that is the commonest reason a settled reaction flares again. Equally, never start a steroid from a previous prescription on your own — if the symptom is an infection, that is the wrong drug.
Long term
Most reverse; hormone glands often do not
Skin, gut, liver and joint inflammation usually settle completely. The hormone glands are the exception: a thyroid, pituitary or adrenal gland that has been damaged may not recover, and replacement can be lifelong. In practice that means a daily tablet and a periodic blood test, which people manage without much thought once it is set up. Living with long-term immunotherapy covers what that looks like month to month.
In-house
Who actually manages this
At CION the immunotherapy itself, the pre-cycle monitoring bloods, and the recognition and treatment of immune-related side effects — including the steroid courses, the hormone replacement and the decision to hold, restart or switch — are delivered in-house by our own medical oncology team, with the relevant organ specialist brought in when needed. Nephrectomy, ablation and PET-CT are coordinated with specialist urology, uro-oncology and interventional radiology partners, where they may also be billed.
Where the decision is actually made. Whether a reaction means a hold, a steroid course, a permanent stop or a change of drug is not one doctor’s call at CION. It goes back to the tumour board, where the severity, your other conditions, how the cancer has been responding and your own priorities are looked at together, and the plan is set along NCCN lines. Ask for the intended next step and the alternative in writing. What each regimen involves, what it costs and what Aarogyasri and cashless insurance cover are on our kidney cancer treatment in Hyderabad page.
Take the first step
Ask who to ring, and what would count as urgent
Before the first dose you should leave with a number to call, a written list of the symptoms that need it, and the name of the person who picks up. Every case at CION goes to a tumour board, not one doctor’s opinion.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Questions people ask about immunotherapy side effects
What are the side effects of immunotherapy for kidney cancer?
They are not the side effects of chemotherapy. Because a checkpoint inhibitor releases a brake across the whole immune system and not only at the tumour, the trouble it causes is inflammation somewhere it is not wanted. The commonest are tiredness, an itchy rash, loose motions, joint aches and an under-active or over-active thyroid. Less often the inflammation settles in the bowel, the liver, the lungs, the kidney itself, or the glands that control other hormones. Most people get something, most of it is mild, and a smaller number get a reaction that needs treatment in its own right. Low blood counts and hair loss, which people expect from chemotherapy, are not typical of this class.
How soon do immunotherapy side effects start?
There is no fixed timetable, and that is the main thing to understand. Skin problems and tiredness tend to appear earliest, often within the first few weeks. Bowel and liver inflammation more often show up after a couple of months. Thyroid and other hormone changes can appear later still, sometimes gradually enough that the tiredness gets put down to the cancer itself. Some reactions begin only after treatment has finished, occasionally months later, which is why you should tell any doctor you see that you have had immunotherapy, even if the course ended a while ago. Combination immunotherapy tends to bring reactions on earlier and more often than a single agent does.
Which immunotherapy side effects should I report the same day?
Ring your treating team, rather than waiting for the next appointment, for any of these: diarrhoea that is more frequent than usual or is not settling, especially with tummy pain, blood or mucus; new breathlessness or a dry cough; yellowing of the eyes or skin, or very dark urine; a rash that is spreading, blistering or involves the mouth; severe tiredness with dizziness or feeling faint on standing; a persistent new headache or a change in vision; passing much less urine than usual. None of these means something has gone badly wrong. Reported early, most settle with treatment. Left for weeks, they are harder to reverse.
How are immune-related side effects treated?
By calming the immune reaction down, and how hard depends on how severe it is. A mild reaction is often managed with simple measures, such as a cream, an antihistamine or a rehydration plan, while treatment carries on. A moderate one usually means holding the next dose and starting a corticosteroid, which damps the immune response, then reducing it slowly over several weeks rather than stopping abruptly. A severe reaction means admission, higher-dose steroid given into a vein, and sometimes a second immune-suppressing drug class if steroid alone is not enough. At CION this is managed in-house by our medical oncology team, with the relevant organ specialist brought in when it is needed.
Will I have to stop immunotherapy if I get a side effect?
Usually not permanently. Most reactions are handled with a hold, meaning the next dose is delayed while the problem is treated, and treatment restarts once things have settled and the steroid dose is low enough. Some organs are handled differently again: an under-active thyroid is usually corrected with hormone replacement and treatment carries straight on, because the problem is replaceable rather than dangerous. A small number of reactions, particularly severe inflammation of the lungs, liver, bowel or the hormone-controlling glands, mean the drug is stopped for good. If that happens there are other options along NCCN lines, and your oncologist should set out the alternative in the same conversation.
Are immunotherapy side effects permanent?
Most are not. Skin, bowel and liver inflammation usually settle fully once treated, and people go back to how they were before. The main exception is the hormone glands. If the thyroid, or less often the pituitary or adrenal glands, is damaged, the gland may not recover and you may need hormone replacement long term. That sounds worse than it is in practice: replacement is a daily tablet, checked with a blood test, and people live normally on it. Tiredness and joint aches can linger for a while after treatment ends. Anything that continues is worth raising with your team rather than putting up with, because it is often manageable.
This page is general health information about the immune-related side effects of checkpoint-inhibitor treatment for kidney cancer. It is not a diagnosis, it is not a prognosis, and it cannot replace a specialist review of your own scans, pathology and blood results. Only a doctor who has seen your reports and examined you can say what a new symptom is caused by or how it should be treated. Do not start, stop or change any medicine, including a steroid, on the strength of a web page. If you are on immunotherapy now, contact your treating team the same day about persistent diarrhoea, a new rash, breathlessness or a dry cough, yellowing of the eyes, severe tiredness with dizziness, new headaches or reduced urine — immune-related side effects are far easier to settle when they are reported early.